Metabolic control probability in tumour subvolumes or how to guide tumour dose redistribution in non-small cell lung cancer (NSCLC): An exploratory clinical study

This publication has 33 references indexed in Scilit:

• Identification of residual metabolic-active areas within individual NSCLC tumours using a pre-radiotherapy 18Fluorodeoxyglucose-PET-CT scan
  Radiotherapy and Oncology, 2009
• Dosimetric analysis of the patterns of local failure observed in patients with locally advanced non-small cell lung cancer treated with neoadjuvant chemotherapy and concurrent conformal (3D-CRT) chemoradiation
  Radiotherapy and Oncology, 2008
• Exploring the role of cancer stem cells in radioresistance
  Nature Reviews Cancer, 2008
• Primary Tumor Standardized Uptake Value (SUVmax) Measured on Fluorodeoxyglucose Positron Emission Tomography (FDG-PET) is of Prognostic Value for Survival in Non-small Cell Lung Cancer (NSCLC): A Systematic Review and Meta-Analysis (MA) by the European Lung Cancer Working Party for the IASLC Lung Cancer Staging Project
  Journal of Thoracic Oncology, 2008
• High Radiation Dose May Reduce the Negative Effect of Large Gross Tumor Volume in Patients With Medically Inoperable Early-Stage Non–Small Cell Lung Cancer
  International Journal of Radiation Oncology*Biology*Physics, 2007
• Correlation of PET/CT Findings and Histopathology after Neoadjuvant Therapy in Non-Small Cell Lung Cancer
  Oncology, 2007
• Imaging oxygenation of human tumours
  European Radiology, 2006
• Metabolic (FDG–PET) response after radical radiotherapy/chemoradiotherapy for non-small cell lung cancer correlates with patterns of failure
  Lung Cancer, 2005
• Estimation of tumor control probability model parameters from 3-D dose distributions of non-small cell lung cancer patients
  Lung Cancer, 1999
• Reporting and analyzing dose distributions: A concept of equivalent uniform dose
  Medical Physics, 1997